Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
OHSU Knight Cancer Institute
Albert Einstein College of Medicine
Eastern Cooperative Oncology Group
Grupo Espanol de Investigacion en Sarcomas
GOG Foundation